Lantheus

QUADRAMET

Manufacturer:

Lantheus

Quadramet HCPCS:

A9604

HCPCS Code Descriptor:

Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries

Category:

A Code

Quadramet NDCs:

11994-0016-01

Primary Type:

Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

11994-0016-01

About Quadramet:

QUADRAMET is a Radiopharmaceutical drug manufactured by Lantheus and administered via the Intravenous route of administration. The A Code: A9604 is aligned to the drug QUADRAMET.

ACCESS PRICING AND MORE BY REGISTERING

A9604 Added Date:

January 1, 2010

A9604 Effective Date:

January 1, 2010

A9604 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Quadramet billing and coding information.
Our team did not identify a source for Quadramet patient assistance information. Please reach out to our team if you feel that this is a mistake.
QUADRAMET prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for QUADRAMET. Please check back in a few weeks.